These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9827943)

  • 21. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of thalassaemia major with phenylbutyrate and hydroxyurea.
    Olivieri NF; Rees DC; Ginder GD; Thein SL; Brittenham GM; Waye JS; Weatherall DJ
    Lancet; 1997 Aug; 350(9076):491-2. PubMed ID: 9274590
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1998 Jun; 850():80-6. PubMed ID: 9668530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL
    Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxyurea in the management of thalassemia intermedia.
    Karimi M
    Hemoglobin; 2009; 33 Suppl 1():S177-82. PubMed ID: 20001623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Curative Effects of Hydroxyurea on the Patients with β-thalassaemia Intermadia].
    Huang L; Yao HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):806-9. PubMed ID: 27342514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia.
    Karimi M; Mohammadi F; Behmanesh F; Samani SM; Borzouee M; Amoozgar H; Haghpanah S
    Eur J Haematol; 2010 Jan; 84(1):52-8. PubMed ID: 19799627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients.
    Chondrou V; Kolovos P; Sgourou A; Kourakli A; Pavlidaki A; Kastrinou V; John A; Symeonidis A; Ali BR; Papachatzopoulou A; Katsila T; Patrinos GP
    Hum Genomics; 2017 Oct; 11(1):24. PubMed ID: 29061162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversing ontogeny.
    Bunn HF
    N Engl J Med; 1993 Jan; 328(2):129-31. PubMed ID: 7677964
    [No Abstract]   [Full Text] [Related]  

  • 36. High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells.
    Khamphikham P; Nualkaew T; Pongpaksupasin P; Kaewsakulthong W; Songdej D; Paiboonsukwong K; Engel JD; Hongeng S; Fucharoen S; Sripichai O; Jearawiriyapaisarn N
    Br J Haematol; 2020 Jun; 189(6):e240-e245. PubMed ID: 32358840
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia.
    Styles L; Lewis B; Foote D; Cuda L; Vichinsky EP
    Ann N Y Acad Sci; 1998 Jun; 850():461-2. PubMed ID: 9668584
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India.
    Chatterjee T; Chakravarty A; Chakravarty S
    Ann Hematol; 2018 May; 97(5):893-898. PubMed ID: 29453624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of mouse beta thalassaemia by hydroxyurea.
    Sauvage C; Rouyer-Fessard P; Beuzard Y
    Br J Haematol; 1993 Jul; 84(3):492-6. PubMed ID: 8217801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.